𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response

✍ Scribed by Ana I. Alvarez; Rebeca Real; Miriam Pérez; Gracia Mendoza; Julio G. Prieto; Gracia Merino

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
266 KB
Volume
99
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis

The present article aims to review the up-to-date information on the most recent studies of the interaction of flavonoids with ABC transporters, in particular the drug pharmacokinetic consequences of such a relationship. In addition, the modulation of the expression of the ABC transporters by flavonoids is also illustrated. Flavonoids are a large group of plant polyphenols present extensively in our daily diets and herbal products. High intake of isoflavones has been associated with a variety of beneficial effects on several common diseases. These polyphenols interact with ABC drug transporters involved in drug resistance and drug absorption, distribution and excretion. A number of studies have demonstrated inhibition of drug transporters by flavonoids. This flavonoid-ABC-transporter interaction could be beneficial for poorly absorbed drugs but could also result in severe drug intoxication, especially drugs with a narrow therapeutic window. On the other hand, flavonoids are themselves substrates of ABC transporters. These proteins can affect the oral availability and tissue distribution of these compounds, modifying their beneficial effects. The challenge is to find a suitable way to predict harmful drug-flavonoid interactions mediated by these transporters.

📜 SIMILAR VOLUMES

Modulation of P-glycoprotein but not MRP
Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979
✍ Robert L. Shepard; Jin Cao; James J. Starling; Anne H. Dantzig 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 188 KB

## Abstract Our study examines the ability of LY335979 (Zosuquidar trihydrochloride) to modulate 3 distinct ABC transporters that are mechanisms of drug resistance: P‐glycoprotein (Pgp, ABCB1), multidrug resistance associated protein (MRP1, ABCC2) and breast cancer resistance protein (BCRP, ABCG2).

Potentiation of the reversal activity of
Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-p-glycoprotein monoclonal antibody MRK-16
✍ Mikihiko Naito; Toru Watanabe; Harumi Tsuge; Tomoko Koyama; Tomoko Oh-Hara; Taka 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 564 KB

SDZ PSC833 (PSC833). an analogue of cyclosporines, is one of the most potent modulators of multi-drug resistance (MDR). We previously reported that MRK-16, an anti-P-glycoprotein MAC. enhanced MDR reversal activity of cyclosporin A (CsA) through inhibition of P-glycoprotein-mediated CrA transport. W

Acidosis induces multi-drug resistance i
Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38
✍ Christoph Sauvant; Martin Nowak; Claudia Wirth; Bettina Schneider; Anne Riemann; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 646 KB

## Abstract Because solid growing tumors often show hypoxia and pronounced extracellular acidosis, the aim of this study was to analyze the impact of an acidotic environment on the activity of the p‐glycoprotein (pGP) and on the cellular content and cytotoxicity of the chemotherapeutic drug daunoru